about
Gene Therapy Applications to Cancer TreatmentGoing viral: a review of replication-selective oncolytic adenovirusesRecent trends in targeted anticancer prodrug and conjugate design.Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinomaEnvelope targeting: hemagglutinin attachment specificity rather than fusion protein cleavage-activation restricts Tupaia paramyxovirus tropism.ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties.Nuclear accumulation of beta-catenin protein indicates activation of wnt signaling in chemically induced rat nephroblastomasProminent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatmentRapid adaptation of a recombinant vesicular stomatitis virus to a targeted cell lineArmed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemiasReplication-selective oncolytic viruses in the treatment of cancer.Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics.Cross-species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live-virus vaccines.p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAsGene therapeutics: the future of brain tumor therapy?An overview on the development of newcastle disease virus as an anti-cancer therapy.Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma.Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastomaOncolytic gene therapy for canine cancers: teaching old dog viruses new tricks.Newcastle disease virus: a promising agent for tumour immunotherapy.Therapeutic potential of oncolytic Newcastle disease virus: a critical review.Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53.CUG2, a novel oncogene confers reoviral replication through Ras and p38 signaling pathway.Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.E2F promoter-regulated oncolytic adenovirus with p16 gene induces cell apoptosis and exerts antitumor effect on gastric cancer.Treatment of implanted mammary tumors with recombinant vesicular stomatitis virus targeted to Her2/neu.p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death.Vesicular stomatitis virus induces apoptosis in the Wong-Kilbourne derivative of the Chang conjunctival cell line.Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector.Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases.Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL.5-Fluorocytosine increases the toxicity of Wnt-targeting replicating adenoviruses that express cytosine deaminase as a late gene.Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10.Soluble receptor-mediated targeting of mouse hepatitis coronavirus to the human epidermal growth factor receptor.Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus.The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411(NTR).
P2860
Q24792808-10E2470A-2249-4574-B22F-DFA189087413Q26797520-1E58875E-083F-4B9A-9E78-8A3AAA21CF6CQ33573762-DAD55D20-B5C3-422B-A164-89AD6BCFC44FQ33868732-C8AF4289-F6EC-480B-8E00-0123083EC489Q33911962-8AB4247A-C1FA-43BD-BE03-5E921CF2C7BEQ34178661-A6C448F2-9204-4C3F-ADB4-82C23C6C4C9BQ34346138-DD163E70-2919-43C3-9930-F8BF2122F887Q34775164-CDCA27F4-ECAC-484F-A26B-48DEBD7DDACFQ35024068-20C58037-B6DF-428A-824C-7823C4E6E565Q35043106-C3E44A6E-67C6-4DA4-A692-DE567D8E9B3BQ35070255-6A9B7947-F237-4136-845C-BE946BD5C3D2Q35912403-AF926203-2F7B-4BCC-BE19-2879E2034510Q35912455-023E6424-B9CA-49FD-9850-B8A226C40E14Q36178513-1E028988-70EB-44EE-B75A-E42EE8DFBB8AQ36512094-2E32AC88-C80F-4809-AF31-686E1366C09FQ36532106-4DAB6C72-AB32-4042-A8C5-DDD3F48F08B4Q36568040-6F01A19C-20C6-4477-B275-04B2D790DA28Q37212969-155C40F0-8688-4CA6-B10E-2467E9CD44A7Q37256658-1E7C4036-23D5-4A96-855E-ABF0A4CF325CQ37582465-C7B995AB-33C9-4E30-9FA4-EF68FC475BB5Q37972664-837F34F6-2B19-4D84-A79C-83C124293170Q38924554-9375A8BB-972C-43CC-A445-4D1B8318E403Q39751672-D6F4F842-C7B5-425B-8399-ECFCA7DEDBADQ39751677-84646197-3C8A-4181-BB60-814FB4B76A1EQ39903499-35752551-C721-499A-9FAD-913DF7D2DA42Q39912230-DBD6009F-D3F6-46E5-99A5-671A80A139A0Q40160049-8896F478-DE82-4521-AC7C-80CFAA1259FFQ40174557-E35C2416-77AE-472C-9D5C-40FCEAD4D0C3Q40277603-24E7F8AB-4C6A-4D47-ACC0-B9DB91568D75Q40343632-422A8AD6-52E2-42BF-9D4E-F695A8C8A3DBQ40395117-D1E72F26-5F56-4BBD-A6C6-CED413AB3909Q40515045-46F9A9C0-E2C8-4CFB-9601-6B50EB5394F3Q40566666-E889546D-353F-4A40-9DA5-4C5A8448C5EBQ40598062-38327F51-8D8A-4D5F-89B5-0FD77D7B5E04Q40601208-F3034261-2CD8-434B-A7C2-C708337FF775Q40603835-D36E74E2-25F3-432D-879B-9EDFA64AC33CQ40670694-D1749722-7DFE-418A-89A1-17B5FB846B61Q42202353-5E2EE2E3-A807-4E55-93E2-39A980BF95B7Q43493342-442D466A-18CC-4F21-80FF-C9B66CC4F7A9Q44165791-EDAFD638-8F8F-45C3-80B4-87B889254823
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cytolytic viruses as potential anti-cancer agents.
@ast
Cytolytic viruses as potential anti-cancer agents.
@en
Cytolytic viruses as potential anti-cancer agents.
@nl
type
label
Cytolytic viruses as potential anti-cancer agents.
@ast
Cytolytic viruses as potential anti-cancer agents.
@en
Cytolytic viruses as potential anti-cancer agents.
@nl
prefLabel
Cytolytic viruses as potential anti-cancer agents.
@ast
Cytolytic viruses as potential anti-cancer agents.
@en
Cytolytic viruses as potential anti-cancer agents.
@nl
P1476
Cytolytic viruses as potential anti-cancer agents.
@en
P2093
Christopher J A Ring
P304
P356
10.1099/0022-1317-83-3-491
P407
P577
2002-03-01T00:00:00Z